News | January 06, 2025
Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
New research labs and process development services to enable next generation therapeutics
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Subscribe To Our Newsletter & Stay Updated
